These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6365661)

  • 1. Elevated pancreatic glucagon in obesity.
    Starke AA; Erhardt G; Berger M; Zimmermann H
    Diabetes; 1984 Mar; 33(3):277-80. PubMed ID: 6365661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
    Ratzmann KP; Schulz B; Witt S; Ziegler M
    Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma glucagon-immunoreactive components in early life in dogs.
    Ghiglione M; Pascual JM; Rovira A; Calvo G; Valverde I
    Horm Metab Res; 1985 Aug; 17(8):387-90. PubMed ID: 2865202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive glucagon in nondiabetic and diabetic Macaca nigra.
    Howard CF; Van Bueren A
    Horm Metab Res; 1981 Apr; 13(4):203-6. PubMed ID: 7239433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical elevations of plasma glucagon levels in patients after pancreatectomy or gastrectomy.
    Ohtsuka K; Nimura Y; Yasui K
    Jpn J Surg; 1986 Jan; 16(1):1-7. PubMed ID: 3959356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans.
    Alford FP; Zimmet P; Chisholm DJ; Whitehouse S
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):721-5. PubMed ID: 6360432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
    Asano T; Ninomiya H; Kan K; Yamamoto T; Okumura M
    Endocrinol Jpn; 1989 Oct; 36(5):767-73. PubMed ID: 2695321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the liver in glucagon metabolism.
    Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
    J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant inheritance of large molecular weight immunoreactive glucagon.
    Palmer JP; Werner PL; Benson JW; Ensinck JW
    J Clin Invest; 1978 Mar; 61(3):763-9. PubMed ID: 641153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone on acute glucagon and insulin release.
    Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
    Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.